Accurx Scribe review

Accurx Scribe's advantage is distribution: Accurx is used by 98% of GP practices in England and staff in 70% of NHS Trusts, so the scribe arrives inside a platform NHS clinicians already open every day. It transcribes consultations, dictation or meetings into structured notes, generates patient and referral letters, and — for GPs — saves to EMIS and SystmOne with one click. It is DTAC-compliant and meets NHS England's requirements for AI scribe technology, with the underlying engine registered with the MHRA as a Class I medical device. Pricing is transparent and per-patient (roughly £0.65–£1.07 per patient/year for practices, less at ICB volume). The honest caveat: the scribe engine is not Accurx's own — Accurx Scribe is "powered by Tandem", i.e. it runs Tandem Health's AI medical scribe, delivered through Accurx's NHS distribution and integrations. In our hands-on testing of Tandem, note quality was the weak point, with hallucinations appearing more often than from the precision-focused leaders — so Accurx Scribe inherits both Tandem's regulated-compliance strengths and that note-quality question. Provisional until we hands-on test Accurx Scribe specifically. Trade-offs: UK-focused; most valuable if you're already on Accurx; HIPAA / SOC 2 aren't relevant to its NHS-only positioning.